NHS Tayside: FOI release

Information requested

“Can you possibly provide the following information please:

Names of the;
Board’s Medical Director
Clinical Director
General Manager
Clinical Lead for Neurosurgery
HR staff member - 21 June
Other Consultant - 21 June

20 and 25 June 2013 - what exactly were the clinical restrictions placed on Professor Eljamel?

October 2013 - what was the method of communication Tayside received regarding the advice from RCOS?

And who was this information addressed to in NHS Tayside?

26 October 2018 - name of the Associate Medical Director?
Who asked this Associate Medical Director to “review the Board’s approach to initial handling of concerns…””

Response

The Scottish Government holds the information you requested. I have responded to your questions in turn below.

Board’s Medical Director – Professor Andrew Russell
Clinical Director – Mr. Philip McLoughlin, Clinical Director, Specialist Services and Oncology
General Manager – Audrey Warden
Clinical Lead for Neurosurgery – David Mowle

While our aim is to provide information whenever possible, in this instance we are unable to provide some of the information you have requested because an exemption under section 38(1)(b) (personal information) of FOISA applies. The reason why that exemption applies is because the grade of the HR staff member is below the level of seniority which is releasable under the FOISA; and the other Consultant attended the meeting in a personal capacity to support Professor Eljamel.

HR staff member - 21 June – s38(1)(b) (personal information) applies
Other Consultant - 21 June – s38(1)(b) (personal information) applies

20 and 25 June 2013 - what exactly were the clinical restrictions placed on Professor Eljamel?

From the information we hold:

• On 20 June, it was agreed that clinical restrictions would be placed on Professor Eljamel’s practice.
• On 25 June, the restrictions on Professor Eljamel's practice were conducting joint ward rounds with emergency cases reviewed jointly during these ward rounds, junior staff training was restricted, reflective discussions with the Clinical Lead were to take place, and the Clinical Lead would take responsibility for patients under Professor Eljamel's care during this period.

October 2013 - what was the method of communication Tayside received regarding the advice from RCOS? And who was this information addressed to in NHS Tayside?

This information was communicated to NHS Tayside by letter which was addressed to Professor Andrew Russell, Medical Director.

26 October 2018 - name of the Associate Medical Director?

Dr Lee Jordan, Associate Medical Director, Patient Access and Assurance.

Who asked this Associate Medical Director to “review the Board’s approach to initial handling of concerns…”

The information we hold does not state who requested the Associate Medical Director to review the Board’s approach to initial handling of concerns, however, from the information we do hold, we think the request was made by Professor Peter Stonebridge, Medical Director of NHS Tayside in 2018; Dr Annie Ingram, Strategic Director of Workforce and Tracey Passway, Head of Patient Safety, Clinical Governance and Risk Management.

About FOI

The Scottish Government is committed to publishing all information released in response to Freedom of Information requests. View all FOI responses at http://www.gov.scot/foi-responses.